The independent source for health policy research, polling, and news.
24,841-24,860 of 113,179 results
Clinic operators say they may have to return or destroy IUDs, hormonal patches, NuvaRings and birth control pills if they leave the federal family planning program. And since Title X also serves people who want to become pregnant, stocks of hormone treatments might have to be tossed as well.
The federal government will pay for 70 percent of the expanded program, but that's less than what other states that expanded the program have received. Utah is different from other states that expanded health insurance because it decided to extend eligibility to a more limited number of residents than is permitted under the health law. Medicaid news comes out of Florida and North Carolina as well.
"Medicare for All" plans have become something of a litmus test among progressive voters, but a look at how Medicare currently operates--and the treatments it does and does not cover--reveals the pitfalls that await if a proposal like that is ever passed. Meanwhile, candidates get tripped up by private insurers' role in a new health system. And while many are painting the picture of a health system in crisis, the numbers provide a more nuanced reality.
Sen. Bernie Sanders (I-Vt.) led a group of people buying insulin across the border into Canada where a vial of the drug costs about a tenth of what it does just an hour away in Michigan. Sanders has long hammered the point that corporate greed is driving prices sky-high.
Sen. Kamala Harris (D-Calif.), a 2020 presidential hopeful, splits the difference between the plans from rivals Sen. Bernie Sanders (I-Vt.) and former Vice President Joe Biden. Her plan would give consumers a choice of joining a government plan modeled on Medicare or choosing from insurance policies modeled on those in Medicare Advantage, and would be run by private insurers rather than the government. “If they want to play by our rules, they can be in the system. If not, they have to get out," Harris said of the insurance companies. Her shifting position on whether they would be included in her health plan has brought her criticism in the past.
Today's early morning highlights from the major news organizations.
Editorial and opinion writers delve into health topics ranging from drug prices to burnout in medicine, medical debt, suicide and more.
Each week, KHN finds interesting reads from around the Web.
Media outlets report on news from California, D.C., Wisconsin, Florida, Maryland, Texas, Georgia, Iowa, Ohio, Pennsylvania and Florida.
Experts offer tips on how to tell the difference between a quality site and one full of misinformation. In other quality news, a new study finds that very few medical journals report conflicts of interest held by their editorial staffs.
"As the water is getting warmer by a few degrees the bacteria is flourishing for longer periods," said Dr. Sally Alrabaa, an an infectious disease specialist. In other public health news: a "brain-eating" amoeba, CRISPR, the benefits of talking to strangers, cyberbullying, gender gaps in STEM fields, and more.
Superior Court Judge Winifred Smith said the jury's billion-dollar punitive damages awards were excessive and unconstitutional. Bayer faces Roundup cancer lawsuits by more than 13,400 plaintiffs across the United States.
A handful of initial public offerings are expected to be a litmus test as more companies consider going public. In other news from the intersection of health care and technology, the VA to spend billions to maintain its current EHR system through a transition to Cerner, a medicine company plans a comeback, the questionable motives at the heart of a hospital's offer from free screenings, and more.
Rep. Elijah Haahr says that he'd be open to an investigation--which Democrats are pushing for--if he doesn't get satisfactory answers. Medicaid news comes out of Illinois and Florida, as well.
Court cases over the opioid epidemic are putting an embarrassing spotlight on McKinsey's strategic advice that's usually kept strictly behind a curtain. One lawsuit stated that McKinsey advised a pharmaceutical company to “get more patients on higher doses of opioids” and study techniques “for keeping patients on opioids longer.” In other news on the epidemic: Sen. Rob Portman (R-Ohio) rails against companies that he says have hurt Americans through the crisis, the Massachusetts attorney general is investigating a pharmacy over improper prescriptions for opioids, and more.
Aaron Hull, who oversaw the El Paso region of the border, will be moved to Detroit. Officials with the Border Patrol’s parent agency said Hull’s transfer was part of a routine shuffle of multiple senior staff members and that Mr. Hull’s new assignment was considered temporary.
The newly-formed Vita Nuova Inc. has filed a lawsuit saying it has the right to Title X grants. The new group lacks a website and, according to the complaint, has yet to raise funds or build a network of providers. It’s not clear what medical services, if any, it plans to provide. But the move hints at renewed enthusiasm from such groups following the family planning funding rule changes from the administration.
Some states have already begun enshrining protections guaranteed by the Affordable Care Act, but others see the current legal challenge to the health law as an opportunity for Congress to pass a new, improved version. The states' leaders discussed the issue at the summer meeting of the National Governors Association.
Juul “deployed a sophisticated program to enter schools and convey its messaging directly to teenage children,” recruited thousands of online influencers to market its vaping devices to youths and targeted children as young as 8 in summer camp, a memo prepared by an Oversight and Reform subcommittee's staff members claimed. Several committee members said Juul's initiatives appeared similar to past efforts by the tobacco industry to reach young people under the guise of smoking prevention programs.
House Speaker Nancy Pelosi's pep talk came as the House passed a two-year budget deal that lifts the government's borrowing limit. The Senate is expected to approve the measure next week.
© 2026 KFF